Denali Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	-	330.53	108.46	48.66	335.66	Upgrade
Revenue Growth (YoY)	-	204.74%	122.89%	-85.50%	1158.19%	Upgrade
Cost of Revenue	396.44	423.88	358.73	265.35	212.62	Upgrade
Gross Profit	-396.44	-93.35	-250.27	-216.69	123.04	Upgrade
Selling, General & Admin	105.44	103.35	90.48	79.06	60.33	Upgrade
Operating Expenses	105.44	103.35	90.48	79.06	60.33	Upgrade
Operating Income	-501.88	-196.7	-340.74	-295.75	62.72	Upgrade
Interest Expense	-0.3	-	-	-	-	Upgrade
Interest & Investment Income	29.82	7.55	13.14	13.34	5.7	Upgrade
Other Non Operating Income (Expenses)	-	-	-	-	3.6	Upgrade
EBT Excluding Unusual Items	-472.36	-189.15	-327.61	-282.41	72.01	Upgrade
Gain (Loss) on Sale of Investments	35.12	43.95	1.64	-8.75	-0.06	Upgrade
Gain (Loss) on Sale of Assets	14.54	-	-	-	-	Upgrade
Pretax Income	-422.71	-145.19	-325.97	-291.16	71.96	Upgrade
Income Tax Expense	0.07	0.03	0.02	-0.58	0.82	Upgrade
Net Income	-422.77	-145.22	-325.99	-290.58	71.14	Upgrade
Net Income to Common	-422.77	-145.22	-325.99	-290.58	71.14	Upgrade
Shares Outstanding (Basic)	164	137	126	122	109	Upgrade
Shares Outstanding (Diluted)	164	137	126	122	113	Upgrade
Shares Change (YoY)	19.73%	9.43%	3.30%	7.83%	17.88%	Upgrade
EPS (Basic)	-2.57	-1.06	-2.60	-2.39	0.65	Upgrade
EPS (Diluted)	-2.57	-1.06	-2.60	-2.39	0.63	Upgrade
Free Cash Flow	-363.61	-370.93	-262.55	-219.89	413.06	Upgrade
Free Cash Flow Per Share	-2.21	-2.70	-2.09	-1.81	3.67	Upgrade
Gross Margin	-	-28.24%	-230.74%	-	36.66%	Upgrade
Operating Margin	-	-59.51%	-314.16%	-607.78%	18.68%	Upgrade
Profit Margin	-	-43.94%	-300.56%	-597.15%	21.19%	Upgrade
Free Cash Flow Margin	-	-112.22%	-242.06%	-451.88%	123.06%	Upgrade
EBITDA	-500.79	-179.97	-330.36	-287.16	71.25	Upgrade
EBITDA Margin	-	-54.45%	-	-	21.23%	Upgrade
D&A For EBITDA	1.09	16.73	10.38	8.59	8.53	Upgrade
EBIT	-501.88	-196.7	-340.74	-295.75	62.72	Upgrade
EBIT Margin	-	-59.51%	-	-	18.68%	Upgrade
Effective Tax Rate	-	-	-	-	1.14%	Upgrade
Revenue as Reported	-	330.53	108.46	48.66	335.66	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q